Placeholder Banner

BIO Announces Appointment of Dan Durham to Lead Health Policy Section

January 7, 2016

Washington, D.C. (January 7, 2016) – The Biotechnology Innovation Organization (BIO) announced today that long-time healthcare policy expert Dan Durham will be joining BIO as Executive Vice President and will lead the organization’s Health Policy Section.

“Dan is a proven and respected leader in the health policy field and will be an important addition to BIO’s senior management team,” said Jim Greenwood, President & CEO of BIO. “Dan’s unique mix of public and private sector experience -- in both the pharmaceutical development and healthcare coverage and payment system areas -- will allow him to hit the ground running at BIO.  This is a critical time for our industry and for the patients we serve, and we need to make sure that the regulatory and healthcare coverage and payment environment is keeping pace with the stunning advancements happening in the scientific labs of our members.  We must ensure that patients have access to the innovations of today and that our entrepreneurs can continue to develop the breakthroughs of tomorrow.  Dan has the policy experience, the relationships, and the management skills to help us achieve our policy goals and objectives.”

Durham comes to BIO from America’s Health Insurance Plans (AHIP), where he most recently served as Executive Vice President for Strategic Initiatives.  Prior to that, Durham spent four years as AHIP’s Executive Vice President for Policy and Regulatory Affairs.  Durham also served as Interim CEO of AHIP.

Before joining AHIP, Durham served as vice president of policy for the Pharmaceutical Research and Manufacturers of America (PhRMA) from 2005 to 2010.  From 2001 to 2005, Durham served as Deputy Assistant Secretary for Health Policy (acting) and Deputy to the Deputy Assistant Secretary, Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services (HHS).

Prior to joining HHS, Durham worked as an Associate Commissioner for Retirement Policy (acting) and Deputy Associate Commissioner at the Social Security Administration.  He also spent eight years at AARP working on health, economic and federal budget issues.  Before AARP, Durham worked at the Office of Management and Budget (OMB), Executive Office of the President, and as a policy analyst in the California Legislative Analyst Office.

Durham will join BIO on January 18, 2016. Kay Holcombe, who served as interim head of health policy, will return to her role as Senior Vice President, Science Policy.  In this role, Holcombe serves as BIO’s lead PDUFA negotiator and as a special advisor to BIO President & CEO Jim Greenwood.

“I want to thank Kay for stepping in to lead our Health Policy Section over the past year and for ensuring that our members were well served during this important time for our industry,” added Greenwood.

Discover More
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Biden outlining ways the public and private sectors can best work with global partners to ensure that patients around the…
Washington, D.C.  – As the Biotechnology Innovation Organization (BIO) continues to restructure for a stronger and reinvigorated future, the organization announced new leadership for operations and sustainability. Shaye Mandle was named Chief…
Washington, DC – The Biotechnology Innovation Organization (BIO) has appointed Melissa von Stauffenberg as Chief Marketing Officer, effective February 1, 2021. The newly created position emerged from a recent reorganization aimed at driving a…